Murad, H A <br/><br/>
Candesartan, rather than losartan, improves motor dysfunction in thioacetamide-induced chronic liver failure in rats.  [electronic resource] 

 -  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas  Sep 2017 
 - e6665 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>1414-431X 
<br/><br/><label>Standard No.: </label>10.1590/1414-431X20176665  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alanine Transaminase--blood<br/>Ammonia--blood<br/>Angiotensin II Type 1 Receptor Blockers--pharmacology<br/>Animals<br/>Benzimidazoles--pharmacology<br/>Biphenyl Compounds<br/>Disease Models, Animal<br/>End Stage Liver Disease--complications<br/>Enzyme-Linked Immunosorbent Assay<br/>Glutathione--analysis<br/>Liver--drug effects<br/>Liver Cirrhosis--complications<br/>Locomotion--physiology<br/>Losartan--pharmacology<br/>Male<br/>Malondialdehyde--analysis<br/>Motor Disorders--drug therapy<br/>Random Allocation<br/>Rats, Sprague-Dawley<br/>Reproducibility of Results<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Tetrazoles--pharmacology<br/>Thioacetamide<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--blood<br/>gamma-Glutamyltransferase--blood